Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
Featured trial
Episodic Migraine: Phase 3 Study of BOTOX (Botulinum Toxin Type A) for the Prevention of Migraine in Subjects with Episodic Migraine

drug has been approved by the regulatory authorities for use in people with chronic migraine and other specific medical conditions but is not approved with chronic migraine and other specific medical

  • 1 views
  • 21 Apr, 2022
  • 1 location
Featured trial
Do you organize your life around chronic migraine pain?

Do you organize your life around chronic migraine pain?

  • 796 views
  • 08 Nov, 2020
  • 2 locations
Featured trial
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)

This is a 20-week study to evaluate the efficacy, safety, and tolerability of once-daily oral Atogepant for the prevention of migraine in participants with episodic migraine. Treatment groups include 30mg twice daily, 60mg once daily, and placebo. This study will consist of a 4-week screening and baseline period, a 12-week …

  • 358 views
  • 03 Aug, 2020
  • 1 location
Featured trial
Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

We are seeking adult participants for a new clinical research study to evaluate the effectiveness of an investigational drug as a preventative treatment for migraines.

  • 1 views
  • 31 May, 2022
  • 1 location
Featured trial
Migraine

Migraines are more than just headaches. They are debilitating and painful. In addition to headache, migraine symptoms may include nausea, vomiting and sensitivity to light and sound.   Migraine is a common cause of headaches in adults. Population-based studies indicate that between 12 - 16 % of people suffer from …

  • 16 views
  • 30 Jul, 2021
  • 1 location
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary

  • 0 views
  • 21 Jul, 2022
  • 76 locations
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

categorized according to the frequency of attacks as episodic migraine (EM) or chronic migraine (CM). This study will assess the effects of BOTOX in preventing migraine in adult participants with EM.

  • 34 views
  • 27 Jul, 2022
  • 98 locations
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2)

To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.

  • 0 views
  • 21 Jul, 2022
  • 13 locations
Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial

Chronic migraine (CM) is a common and frequent disorder, which has a major impact on the quality of life of migraine sufferers, interfering with physical function, productivity at work, personal

  • 0 views
  • 19 Apr, 2022
  • 1 location
Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy

Chronic migraine is a disabling type of migraine and is often resistant to treatment. Non-pharmacological interventions have been investigated as potential treatment although, unfortunately, the

euthymia
photophobia
headache
anxiety
depression
  • 0 views
  • 26 May, 2022
  • 1 location